Cite
HARVARD Citation
Bai, F. et al. (2023). Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals. JAC-antimicrobial resistance. 5 (2), p. . [Online].